For Retirement - or Any Savings Goal - Be Lazy, Self-Centered
How Much Does That Home Repair Cost? America Answers
Mature, Calm, Rational Nasdaq Surpasses Pre-Bubble High
Is Celgene the Perfect Stock?
Biotechnology company Celgene (CELG) announced it is buying Abraxis BioScience (ABII) for $2.9 billion in cash and stock. With this acquisition, Ceglene is expanding its portfolio of cancer treatments.